Mailbag – Subscriber Questions
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
Weekly Points – August 29th, 2025 – 5 Things to Know in Investing This Week – The Medical Device Takeover Issue
MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash and a contingent value right worth up to $1.00. It’s the second medical device acquisition from the DKI portfolio in the past two years and the third acquisition premium in four years. Steel prices fall as US suppliers increase capacity. Just a couple … Read more
Another Great Month in Macau
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
New Feature – Let’s Talk!
Hi All, Good news. As promised, we’ve implemented a new meeting feature. I’ve opened up two 30 minute slots every Monday starting after the coming holiday weekend. These are private Zoom meetings to discuss whatever is on your mind. Flying V’s Kashif has worked some cool magic here so if you’re a DKI Premium Subscriber … Read more
scPharmaceuticals ($SCPH) – Educational Lessons from a Deal
At DKI, we’ve been making an effort to be more transparent in how we make investment decisions and to provide more educational content. There are several interesting lessons which can be extracted from the recent scPharma takeover announcement. Before we dive in, I want to be clear that while a likely acquisition was a key … Read more
Weekly Points – August 22nd, 2025 – 5 Things to Know in Investing This Week – The Chairman Speaks Issue
Chairman Powell leans dovish in his annual remarks causing risk assets including Bitcoin, gold, equities, and energy to trade up sharply. DKI disagrees with the (potential) decision to cut rates, but still profits from it. The White House will be pleased, but don’t expect the President to start praising Powell in public. Copper tariffs are … Read more
scPharmaceuticals ($SCPH) – Being Acquired by MannKind for a Large Premium
MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. This is the second DKI healthcare device portfolio company acquired in the past two … Read more
scPharmaceuticals ($SCPH) Being Acquired – Large Premium
MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. I’m listening to the conference call right now and will update you later today when … Read more
Weekly Points – August 15th, 2025 – 5 Things to Know in Investing This Week – The CPI vs PPI Issue
This week, we got a lower-than-expected CPI. Hooray, the Fed will cut! Then, we got a higher-than-expected PPI. Oh no, the Fed can’t cut! There’s some evidence that tariffs are raising prices for now, but not nearly as bad as the fiat economist threatened. The US puts a 15% tariff on $NVDA and $AMD chip … Read more
The Prove Webinar Series
This content is for premium members only.
Join Now
Join Now
Already a member? Log in here
